Palliative care in a tertiary neonatal intensive care unit: a 10-year review.


Journal

BMJ supportive & palliative care
ISSN: 2045-4368
Titre abrégé: BMJ Support Palliat Care
Pays: England
ID NLM: 101565123

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 30 03 2018
revised: 10 10 2018
accepted: 07 11 2018
pubmed: 25 11 2018
medline: 26 10 2022
entrez: 25 11 2018
Statut: ppublish

Résumé

When active treatment is no longer in the best interests of the patient, redirection of care to palliation is an important transition. We review, within a tertiary neonatal intensive care unit (NICU), the journey leading to the decision to redirect care, the means of symptom control and the provision of psychosocial supports. A retrospective review of all 166 deaths of NICU-affiliated patients during a 10- year epoch. Medical notes were reviewed, and the provision and type of, or barriers to, effective palliative care was defined. Extreme prematurity accounted for 71/145 (49%) of deaths with relatively high proportions of Māori 17/71 (25%) and Pacific Islanders 9/71 (13%). Almost all eligible infants received some form of palliation. Transition from curative to palliative care was refused by the family in a single case. Median time from decision to redirect care until first recorded action was 80 min, and median time from action until death was 60 min. The majority of infants received some form of comfort cares, (128/166) most commonly morphine (94/128, 73%). Three infants had documented seizure activity or respiratory distress but did not receive any pharmacological intervention. Psychosocial supports were offered in 98/145 (67%) of cases, but only 71/145 (49%) of families were formally offered an opportunity to discuss the infant's clinical course after their death. Clinical documentation of care plans was often incomplete, potentially leading to inconsistent delivery of care, increased risk of symptom breakthrough and/or inadequate psychosocial supports for family. Formal individualised palliative care plans are under development to standardise documentation and improve therapeutic and psychosocial interventions available to the infant and their family.

Identifiants

pubmed: 30470701
pii: bmjspcare-2018-001538
doi: 10.1136/bmjspcare-2018-001538
doi:

Substances chimiques

Morphine Derivatives 0

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e641-e645

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Stanley Ka Fai Ng (SKF)

Department of Paediatrics and Child Health, Nelson Marlborough District Health Board, Nelson Hospital, Nelson, New Zealand stanleykfng@gmail.com.

Ngaire Keenan (N)

Department of Paediatrics and Child Health, Capital & Coast District Health Board, Wellington Regional Hospital, Wellington, New Zealand.

Sophie Swart (S)

Department of Paediatrics and Child Health, Capital & Coast District Health Board, Wellington Regional Hospital, Wellington, New Zealand.

Mary Judith Berry (MJ)

Department of Paediatrics and Child Health, Capital & Coast District Health Board, Wellington Regional Hospital, Wellington, New Zealand.
Department of Paediatrics and Child Health, University of Otago, Wellington, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH